Can a US biotechnology company own an Indian subsidiary?

A foreign-owned Indian company may be possible, but the permitted route and conditions depend on the precise activity, product and current foreign-investment policy. Check applicable rules before finalising ownership or starting regulated work.

Does incorporation allow a biotech company to conduct clinical trials in India?

No. Incorporation does not itself grant permission for clinical trials, regulated research, laboratory work or product marketing. Confirm approvals and ethics or regulatory processes for the specific study and product.

Can the US parent retain biotechnology IP?

The group can structure IP ownership and licences contractually, subject to applicable law and the actual development, funding and use of the IP. Document background IP, new inventions, data rights, confidentiality and intercompany licensing.

AU CorporateGrowing Together

English

US to India · Biotechnology and life sciences

Setting Up an Indian Subsidiary for a US Biotechnology Company

A US biotechnology business may use India for discovery research, bioinformatics, clinical operations, laboratory support, product development, contract research or manufacturing. These models are not interchangeable: regulatory pathways, facility needs, IP risks and commercial responsibilities can differ significantly.

Prepared by AU Corporate's CA-led advisory team · Published 13 October 2026 · General guidance; confirm current rules and project-specific requirements before acting.

Quick answer

How can a US company plan India entry for a US Biotechnology Company

First identify the work planned in India: research and development, clinical research, laboratory services, manufacturing, importing or marketing products. Each activity can trigger different permissions, contracts and quality obligations. Then confirm foreign-investment conditions, IP ownership, data and sample handling, tax, funding and ongoing company compliance before committing to a facility or launch date.

Define the activity before choosing the setup

Separate research and development, clinical research, laboratory testing, manufacturing, importing, distribution and marketing. List the products and technologies involved, whether human or biological samples will be handled, and whether the India team will work for the parent or third-party customers.

List each activity and product separately.
Identify the regulator, facility needs and customer obligations for each activity.

Check entity structure and foreign-investment conditions

A private limited subsidiary may support local hiring, leases, vendor contracts and long-term operations. Verify current FDI policy for the actual activity and whether product-specific licensing or government approvals apply. Do not assume every life-sciences activity follows the same route.

Confirm the ownership route before signing long-term commitments.
Treat company incorporation and product or research permissions as separate tasks.

Map product and research permissions

Depending on the work, review CDSCO, the Department of Biotechnology and relevant institutional or ethics processes. Clinical studies, regulated products and manufacturing may require separate steps; company registration alone does not authorise regulated work.

Confirm study, product, ethics and facility approvals with qualified advisers.
Track approvals and renewals against the actual scope of work.

Protect IP, samples and research data

Document ownership of background IP, inventions, software, protocols, laboratory results, datasets and deliverables. Review parent licences, employee and contractor invention terms, confidentiality, publication rights, material-transfer arrangements and restrictions on sharing research data across borders.

Agree ownership and permitted use of new work before development begins.
Record sample provenance, transfer terms and data-access responsibilities.

Structure intercompany funding and ongoing compliance

Document parent funding, services and technology licences. Review transfer pricing, GST and withholding for the actual arrangement. Include corporate filings, accounting, audit, tax, payroll, foreign-investment reporting and any product-specific renewals in the compliance calendar.

Keep agreements, invoices and evidence of work aligned.
Assign an owner and due date to each recurring obligation.

Official sources to check

Start with official sources and confirm that the information is current for the proposed activity. Regulatory, tax and investment requirements depend on the actual business model, ownership, contracts and product or service.

Related guides

AU Corporate can help map India-side incorporation, tax and compliance workstreams to the proposed operating model.

This article is general information, not legal, tax, regulatory or investment advice. Rules and scheme conditions can change; no approval or incentive is guaranteed.